to page content
to site navigation
Explore the Entrepreneurship.org Resource Center to find resources. Designed with entrepreneurs in mind, our resource center allows you to find materials to grow great ideas.
John G. Melo is the Chief Executive Officer of Amyris Biotechnologies, a synthetic biology company working to reduce the cost of curing malaria and producing lower carbon, second generation bio-fuels. He was previously
president of U.S. Fuels for BP, where he led one of the world's largest petroleum marketing, logistics, and trading businesses. While in this role he successfully grew revenues from $25 billion to $34 billion and increased net cash by $1
billion. During this time his team developed one of the world's most successful ethanol blending and marketing businesses. He also worked on the development of BP's "Helios" re-branding. Prior to his eight years with BP, Mr. Melo was a
director with Ernst & Young in San Jose, California, and a management team member for several Northern California start-ups, including Computer Aided Services and Alldata Corporation. John serves on the Board of Directors for U.S. Oil,
a $1.6 billion energy company, and Cilion, a leading low-cost ethanol manufacturer. John is a member of the Economic Club of Chicago, The Chicago Club, The Chicago Council on Global Affairs, and YPO. He enjoys visiting his home country of
Azores, Portugal, as well as skiing, biking, tennis, golf, and time with his children.
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer,
psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These
products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global
Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health
economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and
Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa;
and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a
member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
Dominic Orr was named President and CEO of Aruba Networks in April 2006. Prior to that, Mr. Orr served as the company's Chairman of the Board. Previously, Dominic Orr was the president of Nortel Networks, Intelligent
Internet Web Systems. He previously served as the president and chief executive of Alteon WebSystems which was merged with Nortel Networks in Oct. 2000. Mr. Orr has more than 20 years of experience in the computer systems and communication
networking industry and has held senior positions at Bay Networks, Hewlett-Packard and Hughes Aircraft. Mr. Orr. is a member of the Sciences Board of Visitors at UCLA. He holds a BS in physics from City University of New York and a MS and
PhD from California Institute of Technology.
John Doerr joined Intel in 1974 just as they invented the famous "8080" 8 bit microprocessor. At Intel, he held various engineering, marketing and management assignments, and was one of their top-ranked sales executives.
In 1980, he joined Kleiner Perkins Caufield & Byers and sponsored a series of investments including Compaq, Cypress, Intuit, Macromedia, Netscape, Lotus, Millennium Pharmaceuticals, S3, Sun Microsystems, Amazon.com, and Symantec. John
was the founding CEO of Silicon Compilers and currently serves on the Board of Directors of Google, Intuit, Amazon.com, Homestore.com, and Sun Microsystems. His privately held company board seats include Good Technology, and Segway. He
holds patents for computer memory devices he invented as a design engineer at Monsanto. Recent interests include education, the Internet and biotechnology genomics. John was born one of five children and raised in St. Louis, Missouri. He
holds a BS and MS in Electrical Engineering from Rice University and an MBA from the Harvard Graduate School of Business Administration.
Brook Byers has been a venture capital investor since 1972. He has been closely involved with more than forty new technology based ventures, over half of which have already become public companies. He formed the first
Life Sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare, and biotechnology sectors. KPCB has invested in and helped build over 90 Life Sciences
companies which are developing hundreds of products to treat major underserved medical needs representing huge markets in the nearly two trillion dollar healthcare sector. Brook was the founding President and then Chairman of four
biotechnology companies which were incubated in KPCB's offices and went on to become public companies with an aggregate market value over $8 Billion. He is currently on the Board of Directors of eight companies, most recently joining
CardioDX, Genomic Health Incorporated, Five Prime Therapeutics, Nanofluidics and XDx, Inc.. He was formerly a Director of Idec Pharmaceuticals (Chairman), Athena Neurosciences (Chairman), Signal Pharmaceuticals, Arris Pharmaceuticals,
Pharmacopeia, Ligand Pharmaceuticals (Chairman), Hybritech (Chairman), Genprobe, Nanogen, and others. These companies have pioneered the medical uses of molecular biology, monoclonal antibodies, molecular diagnostics and genomics. Brook
was President and a Director of the Western Association of Venture Capitalists and is a contributing author to the book "Guide to Venture Capital". He is currently a Board member of the University of California at San Francisco Medical
Foundation, the California Healthcare Institute, the New Schools Foundation, Stanford's Bio-X Advisory Council, the Stanford Eye Council and TechNet. He is Co-Chair of the current five year, $1.4 billion, UCSF Capital Campaign. He was
formerly a Director of the Entrepreneurs Foundation, t
Jeff Hawkins is the Founder of Numenta, but he is also well known as the co-founder of two companies, Palm and Handspring, and as the architect of many computing products, such as the PalmPilot and the Treo smartphone.
Throughout his life Hawkins has also had a deep interest in neuroscience and theories of the neocortex. His interest in the brain led him to create the non-profit Redwood Neuroscience Institute (RNI), a scientific organization focused on
understanding how the human neocortex processes information. While at RNI, Hawkins developed a theory of neocortex which appeared in his 2004 book, On Intelligence. Along with Dileep George and Donna Dubinsky, Hawkins
founded Numenta in 2005 to develop a technology platform derived from his theory. It is his hope that Numenta will play a catalytic role in creating an industry based on this theory and technology. Jeff Hawkins earned his B.S. in
electrical engineering from Cornell University in 1979. He was elected to the National Academy of Engineering in 2003.
Prior to Good Technology, Mr. Shader served as a Vice President and General Manager at Amazon.com, which he joined upon the company's acquisition of Accept.com, a company he co-founded and led as CEO. Accept.com was the
first consumer-to-consumer, Internet-based, payment services provider. Mr. Shader's involvement in both Accept.com and Good Technology resulted from his two experiences as an entrepreneur-in-residence with Kleiner Perkins Caufield &
Byers and Benchmark Capital. Previously, he served as Vice President of Partner and Developer Relations at Netscape Communications Corporation, where he also built Netscape's international marketing team. Before joining Netscape, he served
as Vice President of OEM Sales and Business Development at Collabra Software, Inc., which Netscape acquired, and worked for GO Corporation, a pioneer in pen computing. Mr. Shader received a B.S. in Industrial Engineering and Operations
Research from University of California at Berkeley, and an M.B.A. from Stanford University.
Mark Zuckerberg is the founder of Facebook, a networking tool used by college students to meet people, reconnect with old friends and arrange events. The company just redesigned its Web site and received venture capital.
Founded as Thefacebook in February 2004 by Mark Zuckerberg, Chris Hughes, and Dustin Moskovitz at Harvard, the website spread across campus and, within a few weeks, over half the undergraduate population had registered. The website then
expanded to allow students from Columbia, Stanford, and then other Ivy League colleges to register. It became something of a network phenomenon, spreading rapidly to other schools, despite some competition from similar, local websites.
Courtesy of http://www.accel.com/people/index.php, http://en.wikipedia.org/wiki/Facebook. http://www.msnbc.msn.com/id/6596533/site/newsweek, and http://www.seacoastonline.com/news/09082005/biz_nati/61811.htm.
As VP of Products, Jeff's deep passion for the online consumer directs the website experience and drives feature and product innovation. He has played an integral role in many other aspects of the company, including
research and development, manufacturing, and customer service. Jeff holds a Bachelor of Arts degree in Economics from Stanford University.
Janice Fraser is the CEO and a founding partner of Adaptive Path. She has worked in high-tech media for more than 15 years as an entrepreneur, interaction designer, and editor. She joined the internet back when the blink
tag was big, and began to pioneer consumer Web applications for Netscape in 1996. Her current work focuses on leadership for user experience managers and the role of user experience in the changing landscape of product innovation. Janice
has been a featured speaker at nearly every Web-centered design conference, from the Nielsen/Norman world tour to South by Southwest Interactive. She is the founder of four startup companies and was previously managing editor for IDG
Communications. For many years Janice taught interaction design at San Francisco State University's Multimedia Studies Program. Although Time magazine once called her a "grizzled and cynical veteran" of the dot-com era, she remains an
unapologetic champion of user-centered design as a value-producing investment.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
A robust online curriculum for entrepreneurs.
Explore Founders School >
A network of U.S. cities facilitating a weekly entrepreneur education program. Go to 1 Million Cups >
Whether you are starting or growing a company, FastTrac will help you live your dream at each stage.
Get started with FastTrac >